STABLE SUBCUTANEOUS PROTEIN FORMULATIONS AND USES THEREOF

The present invention relates generally to stable formulations comprising CTLA4Ig molecules, including lyophilized, and liquid formulations for administration via various routes including, for example, routes such as intravenous (IV) and subcutaneous (SC) for treating immune system diseases and tole...

Full description

Saved in:
Bibliographic Details
Main Authors Dahlheim, Charles E, Naringrekar, Vijay H, Desai, Manisha P, Borsadia, Sunita, Gandhi, Rajesh Babulal, Nerurkar, Manoj
Format Patent
LanguageEnglish
Published 20.12.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention relates generally to stable formulations comprising CTLA4Ig molecules, including lyophilized, and liquid formulations for administration via various routes including, for example, routes such as intravenous (IV) and subcutaneous (SC) for treating immune system diseases and tolerance induction.
AbstractList The present invention relates generally to stable formulations comprising CTLA4Ig molecules, including lyophilized, and liquid formulations for administration via various routes including, for example, routes such as intravenous (IV) and subcutaneous (SC) for treating immune system diseases and tolerance induction.
Author Gandhi, Rajesh Babulal
Borsadia, Sunita
Naringrekar, Vijay H
Nerurkar, Manoj
Desai, Manisha P
Dahlheim, Charles E
Author_xml – fullname: Dahlheim, Charles E
– fullname: Naringrekar, Vijay H
– fullname: Desai, Manisha P
– fullname: Borsadia, Sunita
– fullname: Gandhi, Rajesh Babulal
– fullname: Nerurkar, Manoj
BookMark eNrjYmDJy89L5WSwDA5xdPJxVQgOdXIODXH0c_UPDVYICPIPcfX0U3DzD_IN9XEM8fT3C1Zw9HNRCA12DVYI8XANcvV342FgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8aHBRgaGFsZmBpZmpo6GxsSpAgByAyvi
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2018360965A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2018360965A13
IEDL.DBID EVB
IngestDate Fri Jul 19 14:28:38 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2018360965A13
Notes Application Number: US201816121287
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20181220&DB=EPODOC&CC=US&NR=2018360965A1
ParticipantIDs epo_espacenet_US2018360965A1
PublicationCentury 2000
PublicationDate 20181220
PublicationDateYYYYMMDD 2018-12-20
PublicationDate_xml – month: 12
  year: 2018
  text: 20181220
  day: 20
PublicationDecade 2010
PublicationYear 2018
RelatedCompanies BRISTOL-MYERS SQUIBB COMPANY
RelatedCompanies_xml – name: BRISTOL-MYERS SQUIBB COMPANY
Score 3.1791081
Snippet The present invention relates generally to stable formulations comprising CTLA4Ig molecules, including lyophilized, and liquid formulations for administration...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title STABLE SUBCUTANEOUS PROTEIN FORMULATIONS AND USES THEREOF
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20181220&DB=EPODOC&locale=&CC=US&NR=2018360965A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LSwMxEB5KFfWmVfFRJaDsbXFN93koso8sVboPuhvprXQfgiDbYlf8-05iqz31lmRgSAIzXyaZ-QJwb8-pXVHnTfBpV6pePs7VAmFRNRF-Brat15asSotic8T1l6kx7cDHphZG8oR-S3JEtKgS7b2V_nr5f4kVyNzK1UPxjkOLpzAfBso6OhZwRTUl8IYsTYLEV3x_yDMlnkjZwBRUJy7GSnt4kLaEPbBXT9SlLLdBJTyG_RT1Ne0JdOqmB4f-5u-1HhxE6ydvbK6tb3UKTpa73piRjHs-z92YJTwj6STJ2XNMMJqL-Pi3Kpi4cUA4ekqSj9iEJeEZ3IUs90cqzmH2t-QZz7YnPDiHbrNo6gsglWFVRk11yzTmel3ZhaPR0qZOZZWIK5p-Cf1dmq52i6_hSHRFugbV-tBtP7_qGwTdtriVe_UDIjh-6g
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LSwMxEB5KFetNq-KjakDZ2-K67z0U2UeWre6jdBPprXQfgiDbYlf8-yax1Z56CxkYJoFvvkwyMwG4t-eqXanOG--nXcl6-TiXC0aLssnoR7NtvbZEVVqSmhHVn6fGtAMfm1oY0Sf0WzRHZIgqGd5b4a-X_5dYgcitXD0U72xq8RSSYSCto2NOV6oiBd4Qj7Mg8yXfH9JcSidCppm81YnLYqU9dsi2OB7wq8frUpbbpBIewf6Y6WvaY-jUTR96_ubvtT4cJOsnbzZco291Ak5OXC_GKKeeT4mb4ozmaDzJCB6liEVzCY1_q4KRmwaIMk-JSIQnOAtP4S7ExI9kZsPsb8kzmm8brJ1Bt1k09TmgyrAqo1Z1yzTmel3ZhaOopa06lVUyXlH0Cxjs0nS5W3wLvYgk8SwepS9XcMhFPHVDVQbQbT-_6mtGwG1xI_btB0Gkgd0
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=STABLE+SUBCUTANEOUS+PROTEIN+FORMULATIONS+AND+USES+THEREOF&rft.inventor=Dahlheim%2C+Charles+E&rft.inventor=Naringrekar%2C+Vijay+H&rft.inventor=Desai%2C+Manisha+P&rft.inventor=Borsadia%2C+Sunita&rft.inventor=Gandhi%2C+Rajesh+Babulal&rft.inventor=Nerurkar%2C+Manoj&rft.date=2018-12-20&rft.externalDBID=A1&rft.externalDocID=US2018360965A1